Get the Stockscreener App
0.3195
8.61%
-0.0301
After Hours:
.31
-0.0095
-2.97%
Clearside Biomedical Inc stock is traded at $0.3195, with a volume of 1.35M.
It is down -8.61% in the last 24 hours and down -26.38% over the past month.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
See More
Previous Close:
$0.3496
Open:
$0.34
24h Volume:
1.35M
Relative Volume:
1.29
Market Cap:
$25.08M
Revenue:
$4.17M
Net Income/Loss:
$-27.71M
P/E Ratio:
-0.8635
EPS:
-0.37
Net Cash Flow:
$-22.23M
1W Performance:
-7.66%
1M Performance:
-26.38%
6M Performance:
-63.28%
1Y Performance:
-76.33%
1-Day Range:
$0.3181
$0.3488
1-Week Range:
$0.312
$0.356
52-Week Range:
$0.292
$1.65
Clearside Biomedical Inc Stock (CLSD) Company Profile
Name
Clearside Biomedical Inc
Sector
Industry
Phone
678-270-3631
Address
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Compare CLSD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.3195 | 26.06M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-18-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-25 | Downgrade | Stifel | Buy → Hold |
| Aug-21-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Dec-15-21 | Resumed | Wedbush | Outperform |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| May-13-20 | Initiated | ROTH Capital | Buy |
| Aug-09-19 | Downgrade | Needham | Buy → Hold |
| Nov-05-18 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-05-18 | Downgrade | JP Morgan | Overweight → Underweight |
| Nov-05-18 | Downgrade | Stifel | Buy → Hold |
| Mar-06-18 | Reiterated | Needham | Buy |
| May-25-17 | Initiated | JMP Securities | Mkt Outperform |
| Feb-24-17 | Initiated | JP Morgan | Overweight |
| Nov-10-16 | Reiterated | Needham | Buy |
| Oct-24-16 | Reiterated | Stifel | Buy |
View All
Clearside Biomedical Inc Stock (CLSD) Latest News
Using AI based signals to follow Clearside Biomedical Inc.Portfolio Performance Summary & Weekly High Potential Stock Alerts - Newser
Analyzing recovery setups for Clearside Biomedical Inc. investorsMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - Newser
Real time scanner hits for Clearside Biomedical Inc. explainedBull Run & Stock Timing and Entry Methods - Newser
Momentum divergence signals in Clearside Biomedical Inc. chartJuly 2025 Short Interest & AI Based Buy and Sell Signals - Newser
How to recover losses in Clearside Biomedical Inc. stock2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
News impact scoring models applied to Clearside Biomedical Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - Newser
What high frequency data says about Clearside Biomedical Inc.Weekly Trading Summary & Weekly High Potential Stock Alerts - Newser
Clearside Biomedical Inc. stock trend outlook and recovery pathJuly 2025 Volume & Community Verified Trade Signals - Newser
Clearside Biomedical Announces Reverse Stock Split - MSN
Clearside Biomedical Inc. stock trend forecastWeekly Profit Summary & Step-by-Step Swing Trade Plans - Newser
Understanding Clearside Biomedical Inc.’s price movementLayoff News & Verified Momentum Stock Alerts - Newser
Clearside Biomedical Announces Reverse Stock Split Plan - TipRanks
Clearside BioMedical files for 1-for-15 reverse stock splitSEC filing - MarketScreener
Live market analysis of Clearside Biomedical Inc.Rate Cut & Safe Entry Point Identification - Newser
Applying big data sentiment scoring on Clearside Biomedical Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
Tools to assess Clearside Biomedical Inc.’s risk profileTrade Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Published on: 2025-09-10 03:40:10 - Newser
What momentum shifts mean for Clearside Biomedical Inc.2025 Price Targets & Community Consensus Picks - Newser
Building trade automation scripts for Clearside Biomedical Inc.Weekly Loss Report & Reliable Intraday Trade Plans - Newser
Is Clearside Biomedical Inc. stock reversal real or fakePortfolio Risk Summary & Daily Entry Point Alerts - Newser
Analyzing net buyer seller activity in Clearside Biomedical Inc.Recession Risk & Low Drawdown Investment Ideas - Newser
Intraday pattern recognizer results for Clearside Biomedical Inc.Market Volume Summary & Short-Term Trading Opportunity Alerts - Newser
Using Python tools to backtest Clearside Biomedical Inc. strategiesPortfolio Return Summary & Short-Term Trading Alerts - Newser
Can volume confirm reversal in Clearside Biomedical Inc.Breakout Watch & High Accuracy Swing Trade Signals - Newser
Key metrics from Clearside Biomedical Inc.’s quarterly dataTrade Exit Summary & Verified Stock Trade Ideas - Newser
Published on: 2025-09-08 22:32:03 - Newser
How to interpret RSI for Clearside Biomedical Inc. stock2025 Sector Review & Technical Analysis for Trade Confirmation - Newser
MACD Signals Flash Warning for Clearside Biomedical Inc. StockJuly 2025 Breakouts & High Conviction Investment Ideas - beatles.ru
Clearside Biomedical Inc. Consolidation Zone May Signal Accumulation2025 Growth vs Value & AI Based Buy and Sell Signals - beatles.ru
Clearside Biomedical Secures $3M with Agreement Amendment - MSN
Clearside Biomedical Approves Reverse Stock Split Proposal - MSN
Clearside Biomedical Inc Stock (CLSD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):